GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coherus BioSciences Inc (FRA:8C5) » Definitions » Price-to-Tangible-Book

Coherus BioSciences (FRA:8C5) Price-to-Tangible-Book : (As of May. 17, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Coherus BioSciences Price-to-Tangible-Book?

As of today (2024-05-17), Coherus BioSciences's share price is €1.975. Coherus BioSciences's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €-1.13. Hence, Coherus BioSciences's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Coherus BioSciences's Price-to-Tangible-Book or its related term are showing as below:

During the past 12 years, Coherus BioSciences's highest Price to Tangible Book Ratio was 126.92. The lowest was 4.54. And the median was 14.54.

FRA:8C5's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.85
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Coherus BioSciences's share price is €1.975. Coherus BioSciences's Book Value per Sharefor the quarter that ended in Mar. 2024 was €-0.66. Hence, Coherus BioSciences's P/B Ratio of today is .


Coherus BioSciences Price-to-Tangible-Book Historical Data

The historical data trend for Coherus BioSciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coherus BioSciences Price-to-Tangible-Book Chart

Coherus BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Coherus BioSciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Coherus BioSciences's Price-to-Tangible-Book

For the Biotechnology subindustry, Coherus BioSciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coherus BioSciences's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coherus BioSciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Coherus BioSciences's Price-to-Tangible-Book falls into.



Coherus BioSciences Price-to-Tangible-Book Calculation

Coherus BioSciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=1.975/-1.126
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Coherus BioSciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Coherus BioSciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Coherus BioSciences (FRA:8C5) Business Description

Traded in Other Exchanges
Address
333 Twin Dolphin Drive, Suite 600, Redwood City, CA, USA, 94065
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. Toripalimab is being evaluated in pivotal clinical trials for the treatment of cancers of the lung, breast, liver, skin, kidney, stomach, esophagus, and bladder. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company is also developing CHS-305, a biosimilar of Avastin. The company generates revenue primarily from the United States.

Coherus BioSciences (FRA:8C5) Headlines

No Headlines